Microba Life Sciences Limited
ASX:MAP.AX
0.085 (AUD) • At close July 4, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Omzet
| 12.09 | 5.42 | 4.689 | 3.732 | 2.909 | 1.828 |
| Kosten van de omzet
| 6.185 | 12.193 | 2.323 | 9.037 | 6.962 | 4.318 |
| Brutowinst
| 5.905 | -6.773 | 2.366 | -5.305 | -4.053 | -2.49 |
| Brutowinstmarge
| 0.488 | -1.25 | 0.505 | -1.421 | -1.393 | -1.362 |
| Onderzoek- en ontwikkelingskosten
| 10.836 | 9.337 | 5.384 | 1.539 | 0.163 | 0 |
| Algemene en administratieve kosten
| 12.179 | 7.809 | 8.573 | 0.822 | 1.977 | 1.1 |
| Verkoop- en marketingkosten
| 0.786 | 0.693 | 0.541 | 0.338 | 0.225 | 0.318 |
| Verkoop-, algemene en administratieve kosten
| 12.965 | 4.12 | 9.114 | 2.726 | 3.19 | 2.299 |
| Overige kosten
| 8.947 | 0.003 | 4.817 | 0 | 0 | 0 |
| Bedrijfskosten
| 32.748 | 13.454 | 18.638 | 4.266 | 3.353 | 2.299 |
| Bedrijfsresultaat
| -26.843 | -20.227 | -11.453 | -9.57 | -7.406 | -4.789 |
| Bedrijfsresultaat ratio
| -2.22 | -3.732 | -2.443 | -2.564 | -2.546 | -2.62 |
| Totaal overige inkomsten en kosten netto
| 6.853 | 1.461 | 4.811 | 2.047 | 0.749 | 0.068 |
| Inkomen voor belasting
| -19.99 | -18.769 | -11.461 | -7.524 | -6.657 | -4.721 |
| Inkomen voor belasting ratio
| -1.653 | -3.463 | -2.444 | -2.016 | -2.288 | -2.582 |
| Belastingkosten
| -0.051 | -6.089 | 0.009 | 0 | -0.007 | 0.013 |
| Nettowinst
| -19.938 | -12.68 | -11.47 | -7.524 | -6.651 | -4.734 |
| Nettowinstmarge
| -1.649 | -2.339 | -2.446 | -2.016 | -2.286 | -2.589 |
| WPA (Winst Per Aandeel)
| -0.049 | -0.038 | -0.04 | -0.026 | -0.023 | -0.016 |
| Verwaterde WPA
| -0.049 | -0.038 | -0.04 | -0.026 | -0.023 | -0.016 |
| EBITDA
| -17.101 | -17.067 | -9.863 | -6.282 | -5.529 | -4.024 |
| EBITDA ratio
| -1.414 | -3.149 | -2.104 | -1.683 | -1.901 | -2.201 |